Saturday, April 28, 2012

Bristol-Myers Squibb confirms it's a target of bribery probe - FiercePharma


In a filing Thursday, it just said that the SEC has started a probe of its sales and marketing departments and that last month it received a subpoena tied to the Foreign Corrupt Practices Act (FCPA). Nothing more was disclosed and the company didn't want to comment, reports the Financial Times.

Posted via email from Jack's posterous

No comments: